Drug Profile
Research programme: influenza vaccines - Molecular Express
Alternative Names: L-M2eA; L-M2eA vaccines; M2eA-HD vaccinesLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Molecular Express
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-virus-infections in USA
- 01 Feb 2006 Preclinical trials in Influenza virus infections in USA (unspecified route)